Cardiology Flashcards
(214 cards)
What are the 3 pathological process in Virchow’s triad that contribute to clot formation?
venous stasis, vascular injury, hypercoagulability
What kind of factors activate the clotting cascade?
clotting factors
what kind of factors inhibit the clotting cascade?
anticoagulants
Unfractionated Heparin: mechanism, indications, adverse rxns, contraindications, pregnancy category
Mechanism: potentiates anti-thrombin III to block thrombin (IIa)(thus inhibiting fibrinogen), also blocks IXa, Xa, XIa, and XIIa, prevents coagulation, but DOES NOT affect an established thrombus
Indications: venous thromboembolism prevention and tx, unstable angina, MI, coronary bypass surgery, hemodialysis, angioplasty, IV line flushes
Adverse rxns: bleeding, Heparin induced thrombocytopenia (HIT–platelets
pregnancy category: C: does not cross placenta, caution with hemorrhage, osteoporosis, does not enter breast milk
UFH dosing, monitoring, reversal
dosing: Loading 80 units/Kg IV push, then continuous infusion of 18 units/Kg/hr (continuous because short half life) (lower in elderly) or subQ q8-12 hr if non acute
monitoring: aPTT (activated partial thromboplastin time) in 6 hr, platelets quod x 14 days
reversal: protamine(binds heparin) 1 mg to neutralize 90 units of UFH, max dose 50 mg, infused over 10 minutes (caution for hypotension and anaphylactoid rxns)
what are the pharmacokinetics of UFH?
Binds to endothelial cells, macrophages, and plasma proteins (low bioavailability), non linear clearance (saturable kinetics b/c large dose), half life increases with increasing doses (30-150 minutes, avg 90)
what is the reference range for aPTT and what should it be on UFH?
normal: 25-39 seconds, 45-75 seconds on UFH (1.5-2X control)
what are some of the advantages of Low molecular weight heparins as compared to UFH?
1/3 the size, higher subcutaneous bioavailability (92%), inhibit clotting factor Xa ONLY, very predictable dose response, longer half life, reduced need for lab monitoring
What’s an example of LMWH?
generic: enoxaparin; brand: lovenox
what are the indications for enoxaparin/lovenox?
DVT prophylaxis after hip or knee replacement surgery, or tx for VTE/TE
Is the dosing for prophylaxis (preventative measures) of blood clots higher or lower than dosing for treatment?
lower
what’s the dosing for enoxaparin/lovenox for DVT prophylaxis after hip or knee replacement surgery?
30 mg sc q 12 hr for 7-10 days until ambulatory
what is the dosing for enoxaparin/lovenox for VTE tx?
1 mg/kg sc q 12 h or 1.5 mg/kg sc Q24 hr
what disease would necessitate a lower dose of enoxaparin/lovenox?
severe renal impairment
what are the possible adverse rxns of LMWH?
bleeding, thrombocytopenia (lower incidence HIT than UFH, check on day 3 therapy), injection site hematoma, minor bleeding at site of injection, osteoporosis (less than UFH)
what/when do you monitor LMWH? what’s the therapeutic dose for VTE tx and VTE prophylaxis?
Baseline: PT, INR, APTT, CBC, serum, creatinine, platelets; steady state level 4 hrs after sub doseplatelets q3-5 days for 1st 2 weeks; anti factor Xa activity in pts with CrCl 14 days), no routine monitoring necessary
therapeutic dose VTE tx: 0.5-1 units/ml; VTE prophylaxis 0.2-0.4 units/ml
what’s the reversal for LMWH?
protamine 1 mg per 1 mg enoxaparin, although this cannot neutralize the anticoagulation effect of LMWH completely
What are some examples of other parenteral anticoagulants?
fondaparinux (Factor Xa inhibitor) and Argatroban (direct thrombin inhibitor)
what are fondaparinux’s mechanism, indications, and kinetics? is there a reversal? what are some drug intx?
Mechanism; inhibits factor Xa
indicated: for VTE prophylaxis for LE orthopedic procedures and tx of VTE, also indicated for HIT (unapproved)
kinetics: longer 1/2 life, so only dosed once daily
no reversal
few drug intros b/c not metabolized in liver
what is argatroban’s mechanism, indications, monitoring, adverse affects, and reversal agents?
directly inhibits circulating and bound thrombin (aka synthetic leech saliva), doesn’t bind plasma proteins=predictable dose response
indications: HIT, patient undergoing PTCA, HIT with PTCA, VTE prophylaxis in hip surgery
monitor: aPTT
adverse affects; high incidence of bleeding
no reversal agents
what is warfarin’s MOA, onset of effect, indications, and adverse reactions, and reversal?
MOA: vitamin K antagonist: interferes with hepatic synthesis of vitamin K dependent clotting factors, resulting in depletion of factors II, VII, IX, X, thus the half life is dependent on the half life of these clotting factors, no effect on est. thrombus or already formed clotting factors
onset of effect: 36-72 hours, full effect in 5-7 days
indications: VTE tx/prophylaxis, prosthetic heart valves, atrial fibrillation, TIA/stroke, acute MI, hyper coagulable states, peripheral arterial occlusive disease
adverse reactions: bleeding (minor in 2-10%), skin necrosis (rare, early, 3-8 days after starting–d/c drug, give Vit K and heparin), purple toe syndrome (later onset 3-10 wks, reversible but need to d/c drug)
reversal is vitamin K
What is warfarin’s pregnancy category and contraindications?
Pregnancy category X, CI: patients with add’l risk of hemorrhage, anyone at risk of noncompliance, surgery/dental work (before surgery go off it and after restart with LMWH which works faster), alcoholism (will cause liver damage), spinal anesthesia or spinal injections (don’t want blood in spinal cord)
what are the pharmacokinetics and metabolism of warfarin?
absorbed well in GI tract (97-99%), food in stomach may increase rate but not extent of absorption. >97% bound to plasma proteins like albumin, crosses placenta and through breast milk
metabolism: plasma half life is 1-2 days, longer in elderly with CHF (less blood flow, slower metabolism)
what is the dosing for warfarin?
4-5 mg qd, overlap with heparin for 4-5 days (shorter half-life for heparin, works faster than warfarin); NOTE: very wide range of doses depending on pt, age